Letters NICE on VTE diseases

NICE guideline has weaknesses

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e5099 (Published 31 July 2012) Cite this as: BMJ 2012;345:e5099
  1. Kit Byatt, consultant physician and geriatrician1
  1. 1Hereford County Hospital, Hereford HR1 2ER, UK
  1. christopher.byatt{at}hhtr.nhs.uk

CG144 provides a comprehensive review of the literature and useful practical guidance, but two aspects puzzle me.1 2

Firstly, the Guideline Development Group (GDG) provides no empirical evidence for changing from the current practice of immediate treatment with low molecular weight heparin (LMWH) and scanning when feasible (often in usual working hours) to scanning …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial